PXD029126 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | Redesigned peptide-based LDH5 inhibitors enter cancer cells efficiently and impair proliferation |
Description | Lactate dehydrogenase 5 (LDH5), an enzyme overexpressed in many cancers, is an attractive target for anticancer therapy. Recently, we successfully designed an LDH5 peptide inhibitor, cGmC9, by targeting protein-protein interactions required for LDH5 enzymatic activity. LDH5 is expressed in the cytosol, therefore this peptide inhibitor has to enter cancer cells to hit its target. In this study we designed cGmC9 analogues and evaluated their internalisation, membrane toxicity, and antiproliferative activity against a panel of cancer cell lines with distinct metabolic profiles. Lead analogue [R/r]cGmC9 showed low toxicity and impaired proliferation in triple negative breast cancer cells, and proteomics analysis showed expected compensatory metabolic changes in response to LDH5 inhibition. These results confirm that LDH5 peptide inhibitors enter cancer cells, reach their cytosol, inhibit LDH5 activity and kill glycolytic tumour cells. Small-molecule drugs have been developed to target the substrate/cofactor sites of LDH5, but none has reached the clinic to date due to cross-reactivity associated with targeting NADH binding site, or low potency in vivo associated with poor stability and poor membrane permeability. This is the first study demonstrating ability of a designed peptide to inhibit LDH5 activity in cancer cells, and confirms the potential of using peptides as inhibitors of intracellular protein-protein interactions relevant for cancer pathways. |
HostingRepository | PRIDE |
AnnounceDate | 2025-05-06 |
AnnouncementXML | Submission_2025-05-06_09:04:31.667.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Andrew Lai |
SpeciesList | scientific name: Mus musculus (Mouse); NCBI TaxID: 10090; scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | No PTMs are included in the dataset |
Instrument | TripleTOF 5600 |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2021-10-14 07:58:58 | ID requested | |
⏵ 1 | 2025-05-06 09:04:32 | announced | |
Publication List
Nadal-Buf, í F, Chan LY, Mohammad HH, Mason JM, Salomon C, Lai A, Thompson EW, Craik DJ, Kaas Q, Henriques ST, Peptide-based LDH5 inhibitors enter cancer cells and impair proliferation. Cell Mol Life Sci, 79(12):606(2022) [pubmed] |
10.1007/s00018-022-04633-3; |
Keyword List
submitter keyword: peptide inhibitors,Lactate dehydrogenase |
Contact List
Carlos Salomon |
contact affiliation | Head, Exosome Biology Laboratory, Centre for Clinical Diagnostics, UQ Centre for Clinical Research, University of Queensland, Australia |
contact email | c.salomongallo@uq.edu.au |
lab head | |
Andrew Lai |
contact affiliation | University of Queensland |
contact email | a.lai@uq.edu.au |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD029126 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD029126
- Label: PRIDE project
- Name: Redesigned peptide-based LDH5 inhibitors enter cancer cells efficiently and impair proliferation